
Addressing the Challenges of Undiagnosed Chronic Kidney Disease
Welcome back to another AJMC Insights series. In this episode titled, ‘Addressing the Challenges of Undiagnosed Chronic Kidney Disease’, Manisha Jhamb led the conversation
Episodes in this series

Welcome back to another AJMC Insights series. In this episode titled, ‘Addressing the Challenges of Undiagnosed Chronic Kidney Disease’, Manisha Jhamb led the conversation about the following questions:
What are the primary gaps in coordination across CRM conditions, such as CKD, that contribute to missed early detection?
How does the adoption of uACR and eGFR enhance early CKD detection within a health system?
How can population health efforts enhance uACR and eGFR screening?
What is the connection between elevated uACR and cardiovascular risk?
Manisha Jhamb highlighted the significant burden of silent chronic kidney disease (CKD) and the missed opportunities for early intervention within cardio-renal-metabolic (CRM) care. The discussion emphasized the clinical necessity of using both estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (uACR) to accurately stage disease and predict cardiovascular outcomes. Furthermore, she explored how health systems can leverage population health tools and electronic health record (EHR) automation to reduce the cognitive load on providers and standardize screening workflows.
Throughout the conversation, the expert provided a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.
In the next episode, ‘From Silos to Holistic Care: Implementing Early Detection in CRM Syndrome’, the panelist continues their discussion on cardio-renal-metabolic syndrome and highlight strategies for improving screening rates in high-risk populations like those with hypertension and diabetes.







